SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    María T. Cáceres-Redondo, Fátima Carrillo, María J. Lama, Ismael Huertas-Fernández, Laura Vargas-González, Manuel Carballo, Pablo Mir, Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease, Journal of Neurology, 2014, 261, 3, 561

    CrossRef

  2. 2
    X.-W. Hu, S.-M. Qin, D. Li, L.-F. Hu, C.-F. Liu, Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis, Acta Neurologica Scandinavica, 2013, 128, 2
  3. 3
    Hubert H. Fernandez, Arvydas Vanagunas, Per Odin, Alberto J. Espay, Robert A. Hauser, David G. Standaert, Krai Chatamra, Janet Benesh, Yili Pritchett, Steven L. Hass, Robert A. Lenz, Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results, Parkinsonism & Related Disorders, 2013, 19, 3, 339

    CrossRef

  4. 4
    Sabine Skodda, Thomas Müller, Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson’s disease under duodopa® therapy, Journal of Neural Transmission, 2013, 120, 2, 315

    CrossRef

  5. 5
    Wayne Briner, The Role of Metal Regulatory Proteins in Brain Oxidative Stress: A Tutorial, Oxidative Medicine and Cellular Longevity, 2012, 2012, 1

    CrossRef

  6. 6
    Thomas Müller, Manfred Gerlach, Moussa B.H. Youdim, Peter Riederer, Neurobiology of Psychiatric Disorders, 2012,

    CrossRef

  7. 7
    Thomas Müller, Constanze Jugel, Reinhard Ehret, Georg Ebersbach, Gunar Bengel, Siegfried Muhlack, Fabian Klostermann, Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel, Journal of Neural Transmission, 2011, 118, 9, 1329

    CrossRef

  8. 8
    Thomas Müller, Dirk Woitalla, Siegfried Muhlack, Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson’s disease, Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 383, 6, 627

    CrossRef

  9. 9
    Thomas Müller, Motor complications, levodopa metabolism and progression of Parkinson's disease, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 7, 847

    CrossRef

  10. 10
    Thomas Müller, Siegfried Muhlack, Acute homocysteine rise after repeated levodopa application in patients with Parkinson’s disease, Parkinsonism & Related Disorders, 2010, 16, 10, 688

    CrossRef

  11. 11
    Peter P. Urban, Ingmar Wellach, Siegbert Faiss, Peter Layer, Thorsten Rosenkranz, Karl Knop, Joachim Weis, Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy, Movement Disorders, 2010, 25, 11
  12. 12
    Thomas Müller, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef

  13. 13
    Thomas Müller, Possible Treatment Concepts for the Levodopa-Related Hyperhomocysteinemia, Cardiovascular Psychiatry and Neurology, 2009, 2009, 1

    CrossRef